We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$1.51B
AUM Growth
+$991M
Cap. Flow
+$876M
Cap. Flow %
57.87%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RUBY
Rubius Therapeutics, Inc
RUBY
+$876M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
$919M 60.75%
+38,296,526
New +$876M
EVLO
2
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$222M 14.68%
911,670
– –
DNLI icon
3
Denali Therapeutics
DNLI
$3.67B
$194M 12.82%
8,918,749
– –
MCRB icon
4
Seres Therapeutics
MCRB
$48.1M
$96.3M 6.36%
634,144
– –
QTRX icon
5
Quanterix
QTRX
$173M
$43.5M 2.87%
2,030,495
– –
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$38.2M 2.52%
320,444
– –

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q3 2018 Portfolio in Review

As of Q3 2018, Flagship Pioneering held 6 positions worth $1.51B, up 190% from $522M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering deployed $876M of net new capital in Q3 2018, opening 1 new position. Its largest new stake was Rubius Therapeutics, Inc: 38,296,526 shares worth $919M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's largest Q3 2018 buy was Rubius Therapeutics, Inc: 38,296,526 shares worth $919M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $1.51B portfolio in Q3 2018.
  • Flagship Pioneering opened 1 new position and closed 0 in Q3 2018.
  • Flagship Pioneering's portfolio value rose 190% quarter-over-quarter to $1.51B.

Based on Flagship Pioneering's 13F filing for Q3 2018, filed 13 Nov 2018.